An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the service has taken down violative content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram stated it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously seen patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to possibly significant health risks”.
